Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franziska Hopfner

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Neurology|May 20, 2020
Author response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson diseaseAnton Pottegård, Franziska Hopfner, Mette Wod, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 20, 2015
HTLV-1 associated myelopathy after renal transplantationFelix Gövert, Andi Krumbholz, Karsten Witt, et al.
Neurology|May 26, 2019
Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson diseaseFranziska Hopfner, Mette Wod, Günter U Höglinger, et al.
Neurology|February 25, 2014
ALS2 mutations: juvenile amyotrophic lateral sclerosis and generalized dystoniaUna-Marie Sheerin, Susanne A Schneider, Lucinda Carr, et al.
Neurogenetics|March 29, 2021
Evidence for pathogenicity of variant ATM Val1729Leu in a family with ataxia telangiectasiaAli S Shalash, Thomas W Rösler, Mohamed Salama, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 17, 2022
HOMER-3 Antibodies Were Not Detected in Two German Cohorts of Patients with Multiple System AtrophyMartin Klietz, Sabrina Katzdobler, Johannes Levin, et al.
Brain Research|May 17, 2017
Gut microbiota in Parkinson disease in a northern German cohortFranziska Hopfner, Axel Künstner, Stefanie H Müller, et al.
Human Molecular Genetics|June 2, 2011
Co-aggregate formation of CADASIL-mutant NOTCH3: a single-particle analysisMarco Duering, Anna Karpinska, Stefanie Rosner, et al.
Movement Disorders Clinical Practice|September 5, 2024
Archimedes Spiral Ratings: Determinants and Population-Based Limits of NormalFranziska Hopfner, Anja Tietz, Yuri D'Elia, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 11, 2024
α-Synuclein Seed Amplification Assays from Blood-Based Extracellular Vesicles in Parkinson's Disease: An Evaluation of the EvidenceAlexander Maximilian Bernhardt, Mojtaba Nemati, Fanni Annamária Boros, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Neurology|May 20, 2020
Author response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson diseaseAnton Pottegård, Franziska Hopfner, Mette Wod, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 20, 2015
HTLV-1 associated myelopathy after renal transplantationFelix Gövert, Andi Krumbholz, Karsten Witt, et al.
Neurology|May 26, 2019
Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson diseaseFranziska Hopfner, Mette Wod, Günter U Höglinger, et al.
Neurology|February 25, 2014
ALS2 mutations: juvenile amyotrophic lateral sclerosis and generalized dystoniaUna-Marie Sheerin, Susanne A Schneider, Lucinda Carr, et al.
Neurogenetics|March 29, 2021
Evidence for pathogenicity of variant ATM Val1729Leu in a family with ataxia telangiectasiaAli S Shalash, Thomas W Rösler, Mohamed Salama, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 17, 2022
HOMER-3 Antibodies Were Not Detected in Two German Cohorts of Patients with Multiple System AtrophyMartin Klietz, Sabrina Katzdobler, Johannes Levin, et al.
Brain Research|May 17, 2017
Gut microbiota in Parkinson disease in a northern German cohortFranziska Hopfner, Axel Künstner, Stefanie H Müller, et al.
Human Molecular Genetics|June 2, 2011
Co-aggregate formation of CADASIL-mutant NOTCH3: a single-particle analysisMarco Duering, Anna Karpinska, Stefanie Rosner, et al.
Movement Disorders Clinical Practice|September 5, 2024
Archimedes Spiral Ratings: Determinants and Population-Based Limits of NormalFranziska Hopfner, Anja Tietz, Yuri D'Elia, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 11, 2024
α-Synuclein Seed Amplification Assays from Blood-Based Extracellular Vesicles in Parkinson's Disease: An Evaluation of the EvidenceAlexander Maximilian Bernhardt, Mojtaba Nemati, Fanni Annamária Boros, et al.
Pageof 8